                         SEQUENCE LISTING

<110>  Mayo Foundation for Medical Education and Research
 
<120>  MATERIALS AND METHODS FOR TREATING CANCER

<130>  07039-1804WO1

<150>  US 62/753,485
<151>  2018-10-31

<150>  US 62/679,348
<151>  2018-06-01

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a GM-CSF nucleic acid

<400>  1
gacctgccta cagacccgcc                                                   20


<210>  2
<211>  1458
<212>  DNA
<213>  artificial

<220>
<223>  nucleic acid encoding a chimeric antigen receptor targeting CD19 
       (CAR19)

<400>  2
atggccttac cagtgaccgc cttgctcctg ccgctggcct tgctgctcca cgccgccagg       60

ccggacatcc agatgacaca gactacatcc tccctgtctg cctctctggg agacagagtc      120

accatcagtt gcagggcaag tcaggacatt agtaaatatt taaattggta tcagcagaaa      180

ccagatggaa ctgttaaact cctgatctac catacatcaa gattacactc aggagtccca      240

tcaaggttca gtggcagtgg gtctggaaca gattattctc tcaccattag caacctggag      300

caagaagata ttgccactta cttttgccaa cagggtaata cgcttccgta cacgttcgga      360

ggggggacca agctggagat cacaggtggc ggtggctcgg gcggtggtgg gtcgggtggc      420

ggcggatctg aggtgaaact gcaggagtca ggacctggcc tggtggcgcc ctcacagagc      480

ctgtccgtca catgcactgt ctcaggggtc tcattacccg actatggtgt aagctggatt      540

cgccagcctc cacgaaaggg tctggagtgg ctgggagtaa tatggggtag tgaaaccaca      600

tactataatt cagctctcaa atccagactg accatcatca aggacaactc caagagccaa      660

gttttcttaa aaatgaacag tctgcaaact gatgacacag ccatttacta ctgtgccaaa      720

cattattact acggtggtag ctatgctatg gactactggg gccaaggaac ctcagtcacc      780

gtctcctcaa ccacgacgcc agcgccgcga ccaccaacac cggcgcccac catcgcgtcg      840

cagcccctgt ccctgcgccc agaggcgtgc cggccagcgg cggggggcgc agtgcacacg      900

agggggctgg acttcgcctg tgatatctac atctgggcgc ccttggccgg gacttgtggg      960

gtccttctcc tgtcactggt tatcaccctt tactgcaaac ggggcagaaa gaaactcctg     1020

tatatattca aacaaccatt tatgagacca gtacaaacta ctcaagagga agatggctgt     1080

agctgccgat ttccagaaga agaagaagga ggatgtgaac tgagagtgaa gttcagcagg     1140

agcgcagacg cccccgcgta caagcagggc cagaaccagc tctataacga gctcaatcta     1200

ggacgaagag aggagtacga tgttttggac aagagacgtg gccgggaccc tgagatgggg     1260

ggaaagccga gaaggaagaa ccctcaggaa ggcctgtaca atgaactgca gaaagataag     1320

atggcggagg cctacagtga gattgggatg aaaggcgagc gccggagggg caaggggcac     1380

gatggccttt accagggtct cagtacagcc accaaggaca cctacgacgc ccttcacatg     1440

caggccctgc cccctcgc                                                   1458


<210>  3
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a GM-CSF nucleic acid

<400>  3
tcaggagacg ccgggcctcc                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a GM-CSF nucleic acid

<400>  4
cagcagcagt gtctctactc                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a GM-CSF nucleic acid

<400>  5
ctcagaaatg tttgacctcc                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a GM-CSF nucleic acid

<400>  6
ggccggtctc actcctggac                                                   20


<210>  7
<211>  23
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a CSF2 gene nucleic acid

<400>  7
gacctgccta cagacccgcc tgg                                               23


<210>  8
<211>  19
<212>  DNA
<213>  artificial

<220>
<223>  CSF2 nucleic acid having a deletion caused by a CRISPR/Cas system

<400>  8
gacctgccta cagaccgcc                                                    19


<210>  9
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  CSF2 nucleic acid having an insertion caused by a CRISPR/Cas 
       system

<400>  9
gacctgccta cagaccccgc c                                                 21


<210>  10
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a GM-CSF nucleic acid

<400>  10
gcagtgctgc ttgtagtggc                                                   20


<210>  11
<211>  26
<212>  DNA
<213>  artificial

<220>
<223>  guideRNA targeting a CSF2 gene nucleic acid

<400>  11
ccgacctgcc tacagacccg cctgga                                            26


<210>  12
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  synthetic primer

<400>  12
tgactacaga gaggcacaga                                                   20


<210>  13
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  synthetic primer

<400>  13
tcacctctga cctcattaac c                                                 21


